...Ligand partnered with AstraZeneca's Omthera Pharmaceuticals Inc. subsidiary to develop products to treat dyslipidemia, including hypertriglyceridemia. The products... ...for milestone payments of up to $44.5 million, as well as tiered, mid-to-high, single-digit royalties. Omthera... ...molecule into an inactive prodrug to be activated by enzymes in the liver. AZ acquired Omthera...
...Ligand partnered with AstraZeneca's Omthera Pharmaceuticals Inc. subsidiary to develop products to treat dyslipidemia, including hypertriglyceridemia. The products... ...for milestone payments of up to $44.5 million, as well as tiered, mid-to-high, single-digit royalties. Omthera... ...molecule into an inactive prodrug to be activated by enzymes in the liver. AZ acquired Omthera...